Knight Therapeutics is a great company with a great future. Here is another.
Check out this 3D Signatures video interview with CEO Jason Flowerday
as well as other members of the 3D team explaining the benefits of the 3D Signatures diagnostic platform that examines Telomeres on the ends of Chromosomes.
It identifies cancer with 99.9% accuracy, the stability or aggression of the disease, and the most likely patient outcome saving the patient and healthcare system time, money and guaranteeing better patient outcomes. Personalized diagnostics.
https://bit.ly/2nmnrWO